Hongmu Li

465 total citations
20 papers, 253 citations indexed

About

Hongmu Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongmu Li has authored 20 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongmu Li's work include RNA modifications and cancer (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hongmu Li is often cited by papers focused on RNA modifications and cancer (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hongmu Li collaborates with scholars based in China, Austria and United Kingdom. Hongmu Li's co-authors include Ping Hua, Jun Tao, Rongjun Zou, Songran Yang, Wanting Shi, Youfang Chen, Zhesheng Wen, Minglei Yang, Liling Zheng and Siyu Wang and has published in prestigious journals such as Frontiers in Immunology, European Journal of Pharmacology and BioMed Research International.

In The Last Decade

Hongmu Li

18 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongmu Li China 11 108 75 58 44 43 20 253
Binshan Zha China 8 136 1.3× 41 0.5× 74 1.3× 75 1.7× 17 0.4× 23 293
Meng‐Die Cheng China 10 154 1.4× 51 0.7× 127 2.2× 88 2.0× 26 0.6× 26 310
Bernadeta Chyrchel Poland 10 91 0.8× 196 2.6× 47 0.8× 32 0.7× 22 0.5× 38 322
Laura West United Kingdom 5 46 0.4× 100 1.3× 21 0.4× 68 1.5× 24 0.6× 7 234
Jayakumar Manoharan Germany 7 125 1.2× 40 0.5× 25 0.4× 23 0.5× 21 0.5× 9 269
Songfeng Zhao China 8 100 0.9× 26 0.3× 70 1.2× 53 1.2× 49 1.1× 18 255
Delia I. Fernández Netherlands 8 45 0.4× 46 0.6× 16 0.3× 34 0.8× 28 0.7× 14 232
Daniel S. Gaul Switzerland 6 60 0.6× 46 0.6× 20 0.3× 15 0.3× 46 1.1× 8 215
Pixiong Su China 11 120 1.1× 150 2.0× 90 1.6× 54 1.2× 54 1.3× 33 348
Ruth Fernández‐Sánchez Spain 7 67 0.6× 41 0.5× 20 0.3× 13 0.3× 24 0.6× 7 169

Countries citing papers authored by Hongmu Li

Since Specialization
Citations

This map shows the geographic impact of Hongmu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongmu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongmu Li more than expected).

Fields of papers citing papers by Hongmu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongmu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongmu Li. The network helps show where Hongmu Li may publish in the future.

Co-authorship network of co-authors of Hongmu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hongmu Li. A scholar is included among the top collaborators of Hongmu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongmu Li. Hongmu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Li, Hongmu, et al.. (2024). VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma. Human Cell. 37(4). 1141–1155. 1 indexed citations
4.
Wu, Chun, Hongmu Li, Xuefei Liu, et al.. (2023). PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer. Clinical and Translational Medicine. 13(6). e1303–e1303. 13 indexed citations
5.
Li, Hongmu, et al.. (2023). TP53 Mutations in Esophageal Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. 28(9). 219–219. 12 indexed citations
6.
Li, Hongmu, et al.. (2023). Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer. Frontiers in Bioscience-Landmark. 28(10). 243–243. 5 indexed citations
7.
Li, Hongmu, Miao Yu, Songjie Feng, et al.. (2023). Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation. Frontiers in Immunology. 14. 1162032–1162032. 17 indexed citations
8.
Li, Hongmu, et al.. (2023). A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma. Frontiers in Immunology. 14. 1147528–1147528. 2 indexed citations
9.
Chen, Dongni, Hongli Zhou, Kaican Cai, et al.. (2022). CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling. Journal of Experimental & Clinical Cancer Research. 41(1). 120–120. 26 indexed citations
10.
Li, Hongmu, Lu Tang, Xue Han, et al.. (2022). High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma. Annals of Diagnostic Pathology. 61. 152051–152051. 4 indexed citations
11.
Ren, Qiannan, et al.. (2022). Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma. BMC Cancer. 22(1). 225–225. 15 indexed citations
12.
Li, Hongmu, et al.. (2022). Development of a copper metabolism-related gene signature in lung adenocarcinoma. Frontiers in Immunology. 13. 1040668–1040668. 21 indexed citations
13.
Li, Hongmu, et al.. (2022). Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma. Genes. 13(12). 2295–2295. 10 indexed citations
15.
Sun, Xuejun, Dandan Hong, Haibo Liu, & Hongmu Li. (2020). Acute Mitral Valve Injury Following Percutaneous Left Atrial Appendage Occlusion: A Case Report and Literature Review. The Heart Surgery Forum. 23(6). E743–E745. 2 indexed citations
16.
Zheng, Liling, et al.. (2019). Role and mechanism of cardiac insulin resistance in occurrence of heart failure caused by myocardial hypertrophy. Aging. 11(16). 6584–6590. 27 indexed citations
17.
Li, Hongmu, Xun Ma, Jun Tao, et al.. (2018). Biatrial versus Isolated Left Atrial Ablation in Atrial Fibrillation: A Systematic Review and Meta-Analysis. BioMed Research International. 2018. 1–14. 13 indexed citations
18.
19.
Zou, Rongjun, Jun Tao, Wanting Shi, et al.. (2017). Meta-analysis of safety and efficacy for direct oral anticoagulation treatment of non-valvular atrial fibrillation in relation to renal function. Thrombosis Research. 160. 41–50. 28 indexed citations
20.
Zou, Rongjun, Wanting Shi, Jun Tao, et al.. (2017). Neurocardiology: Cardiovascular Changes and Specific Brain Region Infarcts. BioMed Research International. 2017. 1–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026